FDA Peptide Reclassification 2026: What Researchers Want FDA considers adding a dozen peptides to its bulk drug compounding list RAPS peptides #fda #longevity #glp1 #precisionmedicine #compounding Katherine Erickson BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with